Sepsis: all 1,946 studies

Page 18 of 20. Open to participants first (471), then studies with results posted, then the rest; newest registration first within each.

• Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.CompletedNCT01411670Phase 2
• The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUOCompletedNCT01410578
• Assessment of Peritoneal Immune Response in Patients With Severe Intra-abdominal Sepsis Managed With Laparostomy and Vacuum Assisted Closure (VAC)CompletedNCT01410526
• Evaluation of 70% Ethanol Lock Solution to Prevent Catheter Related Blood Stream Infections in Pediatric PatientsWithdrawnNCT01409772
• Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis PatientsCompletedNCT01406951
• Sepsis Institutional Registry in Hospital Italiano de Buenos AiresCompletedNCT01403935
• Peripheral Perfusion Targeted Fluid ManagementStatus unknownNCT01397474Phase 4
• Topical Emollient TherapyCompletedNCT01396642Not applicable
• IMproved PREdiction of Severe Sepsis in the Emergency DepartmentCompletedNCT01392508
• Comparison the Value of Several Biomarkers of SepsisCompletedNCT01388725
• Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - BrandenburgTerminatedNCT01388686
• Procalcitonin to Shorten Antibiotics Duration in ICU PatientsStatus unknownNCT01379547Phase 3
• Bioimpedance Analysis in Septic Intensive Care Unit (ICU) PatientsCompletedNCT01379404
• SIRS and Bacterial Sepsis Discrimination by Biomarkers in ICUCompletedNCT01378169
• Plasma Inducible Nitric Oxide Synthase (iNOS) Assay and Sepsis StudyTerminatedNCT01371929
• Exercise in Critically Ill Patients With SepsisStatus unknownNCT01364909Not applicable
• Diagnostic and Prognostic Value of Serial Procalcitonin (PCT) Measurements in Critically Ill PatientsCompletedNCT01362920
• Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen SaturationCompletedNCT01362829
• Pro-adrenomedullin as a Prognostic Marker in Neonatal SepsisCompletedNCT01362504
• Clinical Evaluation of Novel Biomarkers in Patients With SepticemiaCompletedNCT01359891
• Peritoneal Vacuum Therapy to Reduce Inflammatory Response From Abdominal Sepsis/InjuryCompletedNCT01355094Not applicable
• Naushero Feroze Neonatal Survival ProjectCompletedNCT01350765Not applicable
• Ethanol Lock for Prevention of Central Line-Associated Blood Stream InfectionsStatus unknownNCT01344590Not applicable
• Lactated Ringer Versus Albumin in Early Sepsis TherapyCompletedNCT01337934Phase 3
• Neonatal Sepsis, Evaluation, BangladeshCompletedNCT01333982Not applicable
• The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney InjuriesCompletedNCT01333657
• Microcirculatory Changes During Magnesium Sulphate Infusion in SepsisCompletedNCT01332734
• The Effect of Ketanserin on the Microcirculation in SepsisCompletedNCT01329887Phase 3
• Zinc and Inflammation in SepsisCompletedNCT01328509
• The Effect of Three Different Fluids(Albumin 5%, Normal Saline, Hydroxyethyl Starch 130 kD) on Microcirculation in Severe Sepsis/Septic Shock PatientsCompletedNCT01319630
• GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic ShockTerminatedNCT01315496Phase 3
• Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)WithdrawnNCT01314066Phase 2
• Early Goal-directed Therapy and Myocardial DysfunctionStatus unknownNCT01312688Not applicable
• Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic ShockCompletedNCT01310790Phase 4
• Perinatal Handwashing Intervention in BangladeshCompletedNCT01309321Not applicable
• Evaluating Central Line Hub Contamination Using a Novel Capping DeviceStatus unknownNCT01301300Phase 1/2
• Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Late-onset Neonatal SepsisStatus unknownNCT01294865
• Goal-directed Resuscitative Interventions During Pediatric Inter-facility Transport (The GRIPIT Trial)TerminatedNCT01293500Not applicable
• Role of Antibiotics in Preventing Infection in Babies Born Through Meconium Stained LiquorCompletedNCT01290003Not applicable
• Lactoferrin Prophylaxis in VLBW and Regulator T-cellsCompletedNCT01287507Not applicable
• Efficacy of Hydrocortisone in Treatment of Severe Sepsis/Septic Shock Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)CompletedNCT01284452Not applicable
• The Effect of Moderate-Dose Steroid Therapy in SepsisCompletedNCT01275638Phase 4
• Safety and Efficacy of Talactoferrin Alfa in Patients With Severe SepsisSuspendedNCT01273779Phase 2/3
• Hypertonic Saline and Terlipressin for Sepsis-associated HypotensionTerminatedNCT01271114Phase 3
• Pilot Study: Lactoferrin for Prevention of Neonatal SepsisCompletedNCT01264536Phase 2
• Effect of L-arginine and Glutamine on PretermCompletedNCT01263041Phase 2/3
• Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing PracticesCompletedNCT01255943
• The Prediction of Preeclampsia/Toxemia in Twin PregnancyStatus unknownNCT01255202
• Effect of the Intensity of Continuous Renal Replacement TherapyCompletedNCT01251081Not applicable
• Pro-inflammatory Cytokines Profile and Mortality Rate of Critically Ill Septic Patients Following PlasmapheresisStatus unknownNCT01249222Not applicable
• End-of-life Decision-making in Patients With Sepsis-related Organ FailureCompletedNCT01247792Not applicable
• Hyperinsulinemic Therapy in SepsisStatus unknownNCT01244178Not applicable
• Hematological Infection Score Compared to the Hospital Standard for Diagnosis of SIRS or Sepsis on ICUCompletedNCT01236703
• Pharmacokinetics and Safety of Ticarcillin-clavulanate in InfantsWithdrawnNCT01229046Phase 1
• Clarithromycin as Immunomodulator for the Management of SepsisCompletedNCT01223690Phase 3
• Probiotics for Prevention Neonatal InfectionTerminatedNCT01214473Not applicable
• Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical PracticeCompletedNCT01212601
• 4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic ShockStatus unknownNCT01211899
• PREMIUM Registry: PRognostic HEModynamIc Profiling in the AcUtely Ill EMergency Department PatientCompletedNCT01208077
• MiRNAs Evaluate the Prognosis of SepsisStatus unknownNCT01207531
• Biological Modulation of Bacterial QSSMs, Innate and Adaptive Immunity by Antibiotics, Probiotics and Prebiotics in Healthy IndividualsCompletedNCT01201577Phase 1
• L-Carnitine Administration in Early SepsisTerminatedNCT01193777Phase 1
• Medical Education for Sepsis Source Control and AntibioticsCompletedNCT01187134Not applicable
• Paracetamol Toxicity in Septic PatientsSuspendedNCT01182974Phase 3
• A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)CompletedNCT01174147
• Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)Status unknownNCT01169168
• Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 AdjuvantTerminatedNCT01164514Phase 1
• Zinc Therapy in Critical IllnessCompletedNCT01162109Phase 1
• PD-1/PD-L1 Pathway Study on Septic PatientsCompletedNCT01161745
• Fish OIL Optimal dosE Determination StudyTerminatedNCT01146821Phase 2
• Rapid Detection of Staphylococcus Aureus in Burn PatientsCompletedNCT01140269Not applicable
• Safety and Efficacy of Procalcitonin Guided Antibiotic Therapy in Adult Intensive Care Units (ICU's)CompletedNCT01139489Not applicable
• Immune Suppression and Ventilator Associated PneumoniasCompletedNCT01135277
• Indicators of Inflammation and Coagulation in SepsisCompletedNCT01128283
• Improved Detection of Neonatal Sepsis Using a Targeted Biomarker AssayCompletedNCT01120678
• Sepsis Pathophysiological & Organisational TimingCompletedNCT01099813
• The Effect of Erythropietin on Microcircualtory Alteration in Intensive Care Unit Patients With Severe SepsisTerminatedNCT01087450
• Randomised Controlled Trial of Needle Free Access Devices in Preventing Hemodialysis Blood Stream InfectionStatus unknownNCT01082770Phase 4
• Clinical Outcomes in Candidemia Patients Based on in Vitro SusceptibilityCompletedNCT01077336
• Mild Therapeutic Hypothermia During Severe SepsisCompletedNCT01069146Not applicable
• Effect of Docosahexaenoic Acid on the Inflammatory Response and Clinical Outcomes From Surgical PatientsCompletedNCT01049529Phase 2
• Study of Hemodynamics of Neonates by Echocardiography and USCOMStatus unknownNCT01045252
• Cerebrovascular Autoregulation During SepsisCompletedNCT01029080
• Simplified Antibiotic Therapy for Sepsis in Young InfantsCompletedNCT01027429Phase 3
• Study of Procalcitonin (PCT)-Guided Antibiotic Use in Severe Sepsis Patients Without Obvious InfectionTerminatedNCT01025180Phase 4
• Lipid Profile in Patients With Severe Sepsis or Septic Shock Under Strict or Liberal Glycemic ControlCompletedNCT01013662Not applicable
• Coagulation Factors, Cytokines and Tissue Injury Markers in SepsisCompletedNCT01012115
• Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis'Status unknownNCT01006499Phase 4
• Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line InfectionsWithdrawnNCT00990392Not applicable
• Procalcitonin Guided Versus Conventional Antibiotic Therapy in Patients With Sepsis in the ICUWithdrawnNCT00987818Not applicable
• Extravascular Lung Water Index in Severe SepsisCompletedNCT00986271Not applicable
• Australasian Resuscitation In Sepsis Evaluation Randomised Controlled TrialStatus unknownNCT00975793Phase 3
• Scandinavian Starch for Severe Sepsis/Septic Shock TrialCompletedNCT00962156Phase 3
• Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe InfectionsCompletedNCT00934011Not applicable
• The Role of Angiopoietin, Tie-2, and Vascular Endothelial Growth Factor (VEGF) in Sepsis-Induced Multiple Organ Dysfunction Syndrome (MODS)Status unknownNCT00908635
• Understanding the Immune Response to Meningitis VaccinesCompletedNCT00901940Phase 3
• Hepatic Mitochondrial Function in SepsisWithdrawnNCT00889083
• Sidestream Dark-Field (SDF) Imaging of the Intestinal MicrocirculationCompletedNCT00883597
• Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress SyndromeCompletedNCT00879606Phase 2
• Early-Onset Sepsis Surveillance StudyCompletedNCT00874367

← Sepsis overview